Meta-analysis of ciltacabtagene autoleucel versus physician’s choice therapy for the treatment of patients with relapsed or refractory multiple myeloma
Year: 2022
Type: review
Study designs: Systematic Review, Meta-Analysis
Authors: Luciano J. Costa, Parameswaran Hari, Jesus G. Berdeja, Valerio De Stefano, Francesca Gay, Becky Hooper, Meaghan Bartlett, Anja Haltner, Emily Rosta, Shaji Kumar, Thomas Martin, Maria-Victoria Mateos, Philippe Moreau, Saad Z. Usmani, Yunsi Olyslager, Jordan M. Schecter, Tito Roccia, Ashraf Garrett, Sam Lee, Tonia Nesheiwat, Lida Pacaud, Changwei Zhou, Imtiaz A. Samjoo, Yi Lin, Joris Diels, Satish Valluri, Katja Weisel
Institutions: University of Alabama at Birmingham, Iovance Biotherapeutics (United States), Sarah Cannon, Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico, University of Turin, EVERSANA (Canada), Mayo Clinic, UCSF Helen Diller Family Comprehensive Cancer Center, Universidad de Salamanca, Instituto de Biología Molecular y Celular del Cáncer de Salamanca, Levine Cancer Institute, Janssen (Belgium), Janssen Research & Development (United States), Legend Biotech (United States), University Medical Center Hamburg-Eppendorf
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4285043563